Common Questions · Prostate surgery · No. 13
Driving, work, blood thinners, and the tissue question
Four practical questions that decide how the fortnight goes, plus one that men rarely ask until afterwards: whether your operation sends anything to the laboratory at all.
By Mr Musaab Yassin, Consultant Urological Surgeon & Andrologist. Oxford and central London.
The clinical decision gets the consultation. These get an afterthought and a leaflet — and then generate most of the phone calls.
Why every source tells you something different
Before the specifics, the thing men find most maddening: guidance genuinely does contradict itself between hospitals. For the same operation you will find two weeks off work in one leaflet and three to four in another; four weeks before driving in one, two in the next, and nothing at all on the NHS page.
That is not carelessness so much as an absence of evidence. There are no trials of when it is safe to drive after a TURP. Each unit has written down a cautious consensus, and the consensuses differ.
Which means the useful question is not "what is the rule?" but "what is the reasoning?" — and the reasoning is usually the same three things: bleeding risk if you strain, catheter logistics, and whether you could perform an emergency stop.
Driving
The common thread across sources is that you should not drive while a catheter is in, and not until you could brake hard without hesitating. In practice that is a couple of days after the least invasive procedures and one to two weeks after resection or enucleation.
Two points that get missed. Your insurer may set its own condition — worth a phone call, because a policy invalidated by driving too soon is a worse outcome than a week on the train. And the limit is usually discomfort rather than danger: men who feel a jolt of pain on braking should not be driving.
Going back to work
For desk work, most men manage within one to three weeks depending on the procedure — days after UroLift, one to two weeks after Rezūm or Aquablation, two to three after TURP, two to four after HoLEP.
Physical work is a different question, and the constraint is bleeding rather than pain. Heavy lifting, straining and long periods of vibration all raise the chance of provoking the secondary bleed at around ten to fourteen days. If your job involves lifting, plan for the longer end of the range and expect to be told six weeks before you are fully unrestricted.
Flying is worth asking about specifically if you have a holiday booked — most surgeons prefer you past the second-week bleeding window before a long flight.
Blood thinners
This is the question with the least published patient-facing information and the most anxiety attached, and it is worth having answered in writing before your admission date.
The general shape, which your own team must confirm because it depends on why you take the drug:
- Clopidogrel is usually stopped around ten days beforehand.
- Warfarin and the direct oral anticoagulants — apixaban, rivaroxaban, edoxaban, dabigatran — are usually stopped two to three days beforehand, sometimes longer depending on kidney function.
- Aspirin is often continued, particularly where it is being taken after a cardiac stent.
The critical point: the reason you are on the drug decides the plan, not the drug itself. A man on apixaban for atrial fibrillation and a man on dual therapy three months after a coronary stent are in entirely different risk categories, and the second may need his surgery deferred rather than his medication stopped.
The choice of operation also matters here. Enucleation and laser techniques have lower bleeding and transfusion rates than resection, which is one reason they are often preferred in men who cannot safely come off anticoagulation.
Never stop a blood thinner on your own reading of a leaflet.
Anaesthetic: asleep or awake?
More variable between providers than most men expect, which is why the leaflets disagree. In this practice the position is settled rather than open, and it differs by operation.
- HoLEP — a spinal anaesthetic with sedation in most cases. You are comfortable and drowsy rather than fully asleep. A general is used where a spinal is unsuitable or you would prefer one, and that is decided with the anaesthetist beforehand.
- Aquablation — a general anaesthetic. There is no spinal or sedation-only option for this one.
- Rezūm — a local anaesthetic with sedation. You are awake but comfortable, and no general is needed.
Elsewhere the picture is genuinely more open. TURP is usually offered under either a general or a spinal, and the choice is often yours. UroLift can be done under general, sedation or local. iTIND involves a general or heavy sedation — and, importantly, the device is removed at a second procedure, which some men do not realise they are agreeing to.
If being awake matters to you, in either direction, say so early. It sometimes influences which procedure is realistic.
Will they find cancer — and will they even look?
Two versions of this question, and the second is the one almost nobody asks in advance.
The finding. Prostate cancer is sometimes discovered in tissue removed for benign obstruction, in a small percentage of men, and it is usually low-grade and clinically insignificant. It is nonetheless a genuine shock when it arrives a fortnight after an operation nobody framed as a cancer test.
The gap. Whether your operation produces tissue to examine at all depends entirely on which one you have. Resection and enucleation remove tissue, and it goes to the laboratory. Vaporising, ablative and implant-based procedures do not produce a specimen — UroLift places implants and removes nothing; Rezūm ablates tissue in place; GreenLight vaporises it.
The difference is measurable. A study comparing Aquablation with HoLEP found incidental prostate cancer in 6.03% after HoLEP against 0.3% after Aquablation, and concluded that histopathological examination of the tissue should not be omitted where it exists.1 Among men later needing treatment for localised prostate cancer, prior HoLEP was associated with favourable pathological outcomes but higher rates of some complications — a reminder that the two pathways interact.2
None of this is an argument for choosing your operation on cancer-detection grounds. It is an argument for sorting out the cancer question before surgery — PSA, and MRI where indicated — rather than relying on an operation that may not send anything to a pathologist.
The question to ask last
Who do I call at two in the morning if I clot off or cannot pass urine?
For private surgery in particular, get a name and a number, and find out which hospital would admit you. A complication at week two does not respect the fact that you paid for the operation elsewhere.
Bottom line
Expect contradictory advice on driving and work, and ask for the reasoning rather than the rule. Get your anticoagulant plan in writing, and never change it yourself. Know which anaesthetic your operation involves, and why that one. And know, before you consent, whether your operation sends anything to the laboratory — because if it does not, the cancer question needs answering another way.
Worth reading alongside: why am I worse before I am better?, and going private: what you are actually buying.
If this sounds like you
A first consultation is £295, and follow-up £190. It usually runs at least twenty minutes; allow up to an hour if you are likely to need a scan, a flow test, or blood or urine tests on the day. You do not need a referral to book privately, and you are under no obligation to proceed with anything.
Send an enquiry · Symptom questionnaire · Compare the treatments, with the evidence
The 5 studies behind this page▾
- Gloger S, Paulics L, Philippou C, et al. Perioperative rates of incidental prostate cancer after Aquablation and holmium laser enucleation of the prostate. Urologia Internationalis. 2024. doi:10.1159/000539014
- Artiles Medina A, Tagalos Muñoz A, Domínguez Gutiérrez A, et al. Outcomes of active treatment for localised prostate cancer after holmium laser enucleation of the prostate: a systematic review and meta-analysis. European Urology Open Science. 2025. doi:10.1016/j.euros.2025.07.011
- Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of bleeding and transfusion outcomes. Current Urology. 2024. doi:10.1097/cu9.0000000000000257
- Triantafyllou P, Arseniou P, Katsimperis S, et al. Complication profile and safety outcomes of Aquablation in the management of BPH. Medicina. 2025. doi:10.3390/medicina61122076
- Chughtai B, Elterman D, Shore N, et al. The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial. Urology. 2021;153:270–276. doi:10.1016/j.urology.2020.12.022
Mr Musaab Yassin is a Consultant Urological Surgeon and Andrologist practising in Oxford and central London. FRCS (Urol). GMC 6118378. Reviewed September 2026.
This page gives general information and does not replace an individual assessment. Anticoagulant and antiplatelet plans in particular must come from the team performing your surgery, in consultation with whoever prescribed the drug — the timings above describe common practice, not instructions for any individual.